Medicare Enrolled

Amparo Gonzalez-Townsend, FNP-C

Physician Assistant · Bay City, TX
702 AVE F NORTH SUITE 3, Bay City, TX 77414
9792459797
Registered in NPPES since 2020
NPI: 1710598131 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Gonzalez-Townsend from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Gonzalez-Townsend? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Gonzalez-Townsend

Amparo Gonzalez-Townsend is a physician assistant in Bay City, TX, with 6 years of NPI registration.

Between the years covered by Open Payments, Gonzalez-Townsend received a total of $2,443 from 38 pharmaceutical and/or device companies across 117 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Gonzalez-Townsend is Moderate — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 6 years of NPI registration $2,443 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$2,443
Total received (2021-2024)
Avg $611/year across 4 years
Top 14% in TX for physician assistant
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
38
Companies
117
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$936
2023
$718
2022
$635
2021
$154

Payments by company (2024)

AstraZeneca Pharmaceuticals LP
$207
Corcept Therapeutics
$144
Gilead Sciences, Inc.
$123
Axsome Therapeutics, Inc.
$70
Boehringer Ingelheim Pharmaceuticals, Inc.
$51
Amgen Inc.
$45
ABBVIE INC.
$43
SHIELD THERAPEUTICS INC
$42
Bayer Healthcare Pharmaceuticals Inc.
$42
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$42
Antares Pharma, Inc.
$39
Merck Sharp & Dohme LLC
$21
PFIZER INC.
$20
Lilly USA, LLC
$17
Verity Pharmaceuticals Inc.
$16
Kowa Pharmaceuticals America, Inc.
$14
Top 3 companies account for 50.6% of 2024 payments
All-time payments by company (2021-2024) ›
AstraZeneca Pharmaceuticals LP
$521
Biohaven Pharmaceutical Holding Company Ltd.
$179
Axsome Therapeutics, Inc.
$159
Corcept Therapeutics
$144
Gilead Sciences, Inc.
$123
Antares Pharma, Inc.
$95
ABBVIE INC.
$92
Kowa Pharmaceuticals America, Inc.
$86
Biohaven Pharmaceuticals, Inc.
$81
Bayer Healthcare Pharmaceuticals Inc.
$76
Arbor Pharmaceuticals, Inc.
$70
Astellas Pharma US Inc
$56
Novo Nordisk Inc
$55
Lilly USA, LLC
$55
Boehringer Ingelheim Pharmaceuticals, Inc.
$51
Amgen Inc.
$45
Shield Therapeutics Inc
$45
JAZZ PHARMACEUTICALS INC.
$45
Merck Sharp & Dohme LLC
$44
SHIELD THERAPEUTICS INC
$42
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$42
Azurity Pharmaceuticals, Inc.
$30
IDORSIA PHARMACEUTICALS US INC
$28
GRT US Holding, Inc.
$25
Hikma Pharmaceuticals USA
$24
Otsuka America Pharmaceutical, Inc.
$23
Baxter Healthcare
$20
PFIZER INC.
$20
Supernus Pharmaceuticals, Inc.
$20
Eisai Inc.
$20
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$19
Ironwood Pharmaceuticals, Inc
$19
GlaxoSmithKline, LLC.
$18
Dexcom, Inc.
$18
Verity Pharmaceuticals Inc.
$16
Novartis Pharmaceuticals Corporation
$14
ARBOR PHARMACEUTICALS, INC.
$12
EISAI INC.
$12
Top 3 companies account for 35.2% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · AIRSUPRA · Adthyza · Auvelity · BELSOMRA · BREZTRI · CAPLYTA · Dayvigo · Dexcom G6 Transmitter · ENTRESTO · EVUSHELD · Edarbi · Edarbyclor · Epclusa · FARXIGA · FASENRA · GARDASIL · Hillrom - Vest System Model 105 Home Care · JARDIANCE · Kerendia · Korlym · LIVALO · Linzess · Livalo · Mitigare · NOCDURNA · NURTEC ODT · Otezla · Ozempic · QUVIVIQ · Qutenza · RELISTOR · REXULTI · Rybelsus · SEGLENTIS · SHINGRIX · SUNOSI · SYNTHROID · Sunosi · TLANDO · Tlando · VRAYLAR · Veozah · XYOSTED
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a physician assistant in Bay City?
Compare physician assistants in the Bay City area by procedure volume, costs, and industry payment transparency.
Browse physician assistants nearby

Geographic Context

Physician assistants in nearby ZIP areas
11
County median income
$55,174
Nearest hospital to ZIP centroid (approximate)
MATAGORDA REGIONAL MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data — No data N/A
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of Moderate. This reflects how much public data is available about a provider. How we calculate this →

Summary

Gonzalez-Townsend is a physician assistant.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Gonzalez-Townsend receive payments from pharmaceutical companies?
Yes. Gonzalez-Townsend received a total of $2,443 from 38 companies across 117 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Gonzalez-Townsend) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →